Lixisenatide

CAS No: 320367-13-3

Purity: 95%

Molar Mass: 4858.49

Chemical Formula: C215H347N61O65S

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Product Name: Lixisenatide

CAS No: 320367-13-3

Purity: 95%

Molar Mass: 4858.49

Chemical Formula: C215H347N61O65S

Synonyms: AVE-0010, Lyxumia, Adlyxin

Storage: Store at -20℃

Sequence: HGEGTFTSDL SKQMEEEAVR LFIEWLKNGG PSSGAPPSKK KKKK

Target: GLP-1 RA

Application: Lixisenatide(CAS: 320367-13-3) is a glucagon-like peptide-1 receptor agonist employed in the field of pharmaceutical chemistry. Acting as an incretin mimetic, it enhances insulin secretion in response to elevated blood sugar levels. Specifically designed for treating type 2 diabetes, Lixisenatide promotes glucose-dependent insulin release and suppresses glucagon secretion. Its targeted action on pancreatic islets makes it a valuable asset in managing diabetes. Beyond its pharmaceutical utility, Lixisenatide exhibits promise in organic chemistry by serving as a molecular tool for investigating signal transduction pathways. Additionally, its potential applications extend to material chemistry, where it can contribute to the development of innovative drug delivery systems, showcasing its versatility across multiple domains.

Reference: Lee, J., Kim, R., Kim, M. H., Lee, S. H., Cho, J. H., Lee, J. M., … & Kim, H. S. (2023). Weight loss and side-effects of liraglutide and lixisenatide in obesity and type 2 diabetes mellitus. Primary Care Diabetes, 17(5), 460-465.